Framingham Risk Score Calculator

The Framingham Heart Study has followed residents of Framingham, Massachusetts, since 1948, identifying the major risk factors for coronary heart disease (CHD). The National Cholesterol Education Program's Adult Treatment Panel III (ATP III, 2001) turned an update of the Framingham risk equations (Wilson et al., 1998) into point tables for a person's 10-year risk of hard CHD: a heart attack (myocardial infarction) or death from coronary disease. This calculator adds up the points and looks up the risk exactly as those tables give them. **What is scored**: - **Age**: sex-specific points - **Total cholesterol**: points that depend on age. They shrink with age, but ATP III notes that cholesterol doesn't matter less: older people already have many points for age, and the risk climbs steeply with each extra point - **Smoking**: any cigarette smoking in the past month, with points that also depend on age - **HDL cholesterol**: 60 mg/dL or more takes a point off; under 40 adds 2 - **Systolic blood pressure**: more points at the same reading if it is being treated, because treated high blood pressure leaves some risk behind **Points for age** (men / women): - 20–34: −9 / −7 - 35–39: −4 / −3 - 40–44: 0 / 0 - 45–49: 3 / 3 - 50–54: 6 / 6 - 55–59: 8 / 8 - 60–64: 10 / 10 - 65–69: 11 / 12 - 70–74: 12 / 14 - 75–79: 13 / 16 **Points for total cholesterol, men** (mg/dL; at ages 20–39 / 40–49 / 50–59 / 60–69 / 70–79): - under 160: 0 / 0 / 0 / 0 / 0 - 160–199: 4 / 3 / 2 / 1 / 0 - 200–239: 7 / 5 / 3 / 1 / 0 - 240–279: 9 / 6 / 4 / 2 / 1 - 280 or more: 11 / 8 / 5 / 3 / 1 **Points for total cholesterol, women** (mg/dL; at ages 20–39 / 40–49 / 50–59 / 60–69 / 70–79): - under 160: 0 / 0 / 0 / 0 / 0 - 160–199: 4 / 3 / 2 / 1 / 1 - 200–239: 8 / 6 / 4 / 2 / 1 - 240–279: 11 / 8 / 5 / 3 / 2 - 280 or more: 13 / 10 / 7 / 4 / 2 **Points for smoking** (at ages 20–39 / 40–49 / 50–59 / 60–69 / 70–79; nonsmokers score 0): - Men: 8 / 5 / 3 / 1 / 1 - Women: 9 / 7 / 4 / 2 / 1 **Points for HDL cholesterol** (mg/dL; men and women): - under 40: 2 - 40–49: 1 - 50–59: 0 - 60 or more: −1 **Points for systolic blood pressure** (mmHg; untreated / treated): - under 120: men 0 / 0, women 0 / 0 - 120–129: men 0 / 1, women 1 / 3 - 130–139: men 1 / 2, women 2 / 4 - 140–159: men 1 / 2, women 3 / 5 - 160 or more: men 2 / 3, women 4 / 6 **10-year risk of hard CHD for the point total**: - Men: under 0 → under 1%; 0–4 → 1%; 5–6 → 2%; 7 → 3%; 8 → 4%; 9 → 5%; 10 → 6%; 11 → 8%; 12 → 10%; 13 → 12%; 14 → 16%; 15 → 20%; 16 → 25%; 17 or more → 30% or more - Women: under 9 → under 1%; 9–12 → 1%; 13–14 → 2%; 15 → 3%; 16 → 4%; 17 → 5%; 18 → 6%; 19 → 8%; 20 → 11%; 21 → 14%; 22 → 17%; 23 → 22%; 24 → 27%; 25 or more → 30% or more **Who the score is for**: adults aged 20 to 79 without heart disease or diabetes. ATP III counts diabetes as a CHD risk equivalent, a 10-year risk over 20% like that of heart disease itself, so this calculator doesn't score it. Men's and women's totals are on different scales, so they can't be compared directly. **ATP III's three levels of 10-year risk**: - Over 20%: a CHD risk equivalent - 10–20% - Under 10% ATP III set LDL cholesterol goals and treatment by these levels. Its tables approximate the Framingham equations, which use exact values rather than bands; ATP III judged the tables accurate for clinical purposes. They are meant to be worked out once, to guide treatment, not to track how risk changes as risk factors improve. NHLBI now marks the ATP III report as an archive, for historical reference. The March 2026 ACC/AHA dyslipidemia guideline recommends PREVENT-ASCVD instead of the older Pooled Cohort Equations for 10- and 30-year risk assessment to guide primary-prevention lipid-lowering therapy in adults aged 30 to 79. PREVENT-ASCVD estimates a different outcome, including stroke, so its figures cannot be compared directly with this ATP III hard-CHD score. Sources: [AHA guideline summary](https://professional.heart.org/en/science-news/2026-guideline-on-the-management-of-dyslipidemia/top-things-to-know) and [ACC announcement, March 13, 2026](https://www.acc.org/about-acc/press-releases/2026/03/13/18/01/accaha-issue-updated-guideline-for-managing-lipids-cholesterol).